Skip to main content
. 2020 Mar 13;12(6):4896–4906. doi: 10.18632/aging.102915

Table 1. Differences of demographics and characteristics for M0 patients of PTMC in different data sets.

Demographics and characteristics Training data (n=15124) Internal testing data (n=6482) External testing data (n=1031) Total (n=22637)
Age (year)
 <55 9388 (62.07) 4081 (62.96) 807 (78.27) 14276 (63.06)
 ≥55 5736 (37.93) 2401 (37.04) 224 (21.73) 8361 (36.94)
Race
 Other1 1524 (10.08) 655 (10.10) 1031 3210 (14.18)
 white 12503 (82.67) 5391 (83.17) / 17894 (79.05)
 black 1097 (7.25) 436 (6.73) / 1533 (6.77)
Sex
 Male 2666 (17.63) 1145 (17.66) 186 (18.04) 3997 (17.66)
 Female 12458 (82.37) 5337 (82.34) 845 (81.96) 18640 (82.34)
Tumor size (mm) 5.51±2.94 5.51±2.97 5.50±2.41 5.51±2.93
Extension
 intrathyroidal extension 14194 (93.85) 6081 (93.81) 967 (93.80) 21242 (93.84)
 minimal extension 868 (5.74) 375 (5.79) 52 (5.04) 1295 (5.72)
 gross extension 62 (0.41) 26 (0.40) 12 (1.16) 100 (0.44)
Multifocality
 Solitary tumor 9684 (64.03) 4173 (64.38) 803 (77.89) 14660 (64.76)
 Multifocal tumor 5440 (35.97) 2309 (35.62) 228 (22.11) 7977 (35.24)
N status
 positive 1812 (11.98) 771 (11.89) 367 (35.60) 2950 (13.03)
 negative 13312 (88.02) 5711 (88.11) 664 (64.40) 19687 (86.97)

Notes: All data was presented as the number of cases and composition ratio (%) or mean ± standard deviation. 1Including American Indian/AK Native, Asian/Pacific Islander.

Abbreviations: M0 = no distant metastases; PTMC = papillary thyroid microcarcinoma.